Total Payments
$3,805
2024 Payments
$1,789
Companies
40
Transactions
225
Medicare Patients
1,484
Medicare Billing
$205,280
Payment Breakdown by Category
Food & Beverage$3,793 (99.7%)
Education$12.16 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,793 | 224 | 99.7% |
| Education | $12.16 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $844.55 | 68 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $371.23 | 21 | $0 (2024) |
| MDD US Operations, LLC | $285.80 | 16 | $0 (2024) |
| Lilly USA, LLC | $215.62 | 10 | $0 (2024) |
| UCB, Inc. | $212.19 | 8 | $0 (2024) |
| Penumbra, Inc. | $147.59 | 1 | $0 (2019) |
| Biohaven Pharmaceutical Holding Company Ltd. | $145.57 | 12 | $0 (2022) |
| PFIZER INC. | $133.08 | 15 | $0 (2024) |
| CSL Behring | $131.33 | 5 | $0 (2024) |
| Celgene Corporation | $106.62 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,789 | 99 | ABBVIE INC. ($381.22) |
| 2023 | $294.22 | 22 | AbbVie Inc. ($230.68) |
| 2022 | $811.15 | 55 | ABBVIE INC. ($190.31) |
| 2021 | $158.42 | 9 | AbbVie Inc. ($42.34) |
| 2020 | $65.59 | 4 | Novartis Pharmaceuticals Corporation ($21.55) |
| 2019 | $462.61 | 22 | Novartis Pharmaceuticals Corporation ($172.12) |
| 2018 | $149.19 | 10 | Novartis Pharmaceuticals Corporation ($34.81) |
| 2017 | $74.54 | 4 | UCB, Inc. ($24.84) |
All Payment Transactions
225 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $9.30 | General |
| Category: PAIN | ||||||
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $0.57 | General |
| Category: PAIN | ||||||
| 12/12/2024 | Amneal Pharmaceuticals LLC | — | Food and Beverage | In-kind items and services | $21.14 | General |
| 12/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $33.97 | General |
| Category: Neurology | ||||||
| 12/03/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.39 | General |
| Category: Analgesic | ||||||
| 11/27/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $6.13 | General |
| Category: PAIN | ||||||
| 11/26/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $2.24 | General |
| Category: PAIN | ||||||
| 11/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Neuropsychiatry | ||||||
| 11/12/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $35.22 | General |
| Category: Musculoskeletal | ||||||
| 11/05/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Immunology | ||||||
| 11/04/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $21.76 | General |
| Category: AMANTADINE | ||||||
| 10/30/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $4.81 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $41.22 | General |
| Category: Neurology | ||||||
| 10/29/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $13.32 | General |
| Category: Neurology | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: Rare Disease | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $12.59 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: PAIN | ||||||
| 10/07/2024 | Vanda Pharmaceuticals Inc. | PONVORY (Drug) | Food and Beverage | In-kind items and services | $38.66 | General |
| Category: MULTIPLE SCLEROSIS | ||||||
| 10/07/2024 | MDD US Operations, LLC | Gocovri (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: AMANTADINE | ||||||
| 10/03/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 355 | 474 | $137,495 | $41,328 |
| 2022 | 4 | 313 | 432 | $140,861 | $36,582 |
| 2021 | 6 | 399 | 540 | $247,677 | $51,729 |
| 2020 | 10 | 417 | 6,573 | $317,545 | $75,642 |
Total Patients
1,484
Total Services
8,019
Medicare Billing
$205,280
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 227 | 338 | $98,350 | $30,083 | 30.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 63 | 63 | $24,035 | $7,382 | 30.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 73 | $15,111 | $3,863 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 171 | 269 | $91,874 | $23,779 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 90 | 102 | $23,490 | $6,195 | 26.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 39 | 39 | $16,301 | $4,973 | 30.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 22 | $9,196 | $1,636 | 17.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 178 | 268 | $116,044 | $25,884 | 22.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 67 | 110 | $45,980 | $9,163 | 19.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 57 | 57 | $46,626 | $8,625 | 18.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 57 | 61 | $17,995 | $3,959 | 22.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $14,652 | $2,822 | 19.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 18 | 22 | $6,380 | $1,275 | 20.0% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 12 | 6,050 | $66,671 | $29,281 | 43.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 107 | 135 | $58,455 | $9,987 | 17.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 52 | 52 | $42,536 | $8,201 | 19.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 59 | 97 | $40,546 | $7,996 | 19.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 82 | 105 | $30,975 | $5,180 | 16.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 33 | 40 | $23,160 | $4,092 | 17.7% |
| 64615 | Injection of chemical for destruction of facial and neck nerve muscles on both sides of face | Office | 2020 | 13 | 33 | $17,428 | $3,886 | 22.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 29 | 29 | $19,314 | $3,487 | 18.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 17 | 17 | $14,110 | $2,653 | 18.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 15 | $4,350 | $879.44 | 20.2% |
About Patrick Bushard
Patrick Bushard is a Neurology healthcare provider based in Lafayette, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2007. The National Provider Identifier (NPI) number assigned to this provider is 1306998448.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Patrick Bushard has received a total of $3,805 in payments from pharmaceutical and medical device companies, with $1,789 received in 2024. These payments were reported across 225 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($3,793).
As a Medicare-enrolled provider, Bushard has provided services to 1,484 Medicare beneficiaries, totaling 8,019 services with total Medicare billing of $205,280. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Vascular Neurology, Neurology
- Location Lafayette, CO
- Active Since 01/17/2007
- Last Updated 07/07/2020
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1306998448
Products in Payments
- BOTOX (Biological) $407.01
- NURTEC ODT (Drug) $278.65
- QULIPTA (Drug) $271.81
- UBRELVY (Drug) $163.07
- Penumbra Jet 7 (Device) $147.59
- KESIMPTA (Drug) $142.75
- EMGALITY (Drug) $134.54
- APOKYN (Drug) $132.21
- Hizentra (Biological) $131.33
- Gocovri (Drug) $112.42
- ZEPOSIA (Drug) $106.62
- INGREZZA (Drug) $78.24
- GILENYA (Drug) $77.08
- NUPLAZID (Drug) $71.69
- Briviact (Drug) $71.40
- AIMOVIG (Biological) $65.56
- Aimovig (Biological) $62.01
- MAYZENT (Drug) $61.52
- ACTIVA (Device) $58.98
- Fintepla (Drug) $57.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lafayette
Anthony Simchak, Md, MD
Neurology — Payments: $838,010
Neurology $838,010
Dr. Fabian Lugo, M.d, M.D
Neurology — Payments: $28,797
Neurology $28,797
Steven Snatic, M.d, M.D
Neurology — Payments: $18,343
Neurology $18,343
Mrs. Virginia Kellner, M.d, M.D
Neurology — Payments: $17,398
Neurology $17,398
Dr. Adam Foreman, M.d, M.D
Neurology — Payments: $16,103
Neurology $16,103
Wael Alabdulkarim, Md, MD
Neurology — Payments: $15,860
Neurology $15,860